SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Morrice Nicholas)
 

Search: WFRF:(Morrice Nicholas) > GFAT1 phosphorylati...

GFAT1 phosphorylation by AMPK promotes VEGF-induced angiogenesis

Zibrova, Darya (author)
Universitätsklinikum Jena
Vandermoere, Franck (author)
University of Montpellier
Göransson, Olga (author)
Lund University,Lunds universitet,Proteinfosforylering,Forskargrupper vid Lunds universitet,Protein Phosphorylation,Lund University Research Groups
show more...
Peggie, Mark (author)
University of Dundee
Mariño, Karina V. (author)
Experimental Medicine and Biology Institute (IByME)
Knierim, Anne (author)
Universitätsklinikum Jena
Spengler, Katrin (author)
Universitätsklinikum Jena
Weigert, Cora (author)
German Center for Diabetes Research,University of Tübingen
Viollet, Benoit (author)
Paris Descartes University,Institut Cochin
Morrice, Nicholas A. (author)
AB Sciex
Sakamoto, Kei (author)
University of Dundee
Heller, Regine (author)
Universitätsklinikum Jena
show less...
 (creator_code:org_t)
2017
2017
English 19 s.
In: Biochemical Journal. - 0264-6021. ; 474:6, s. 983-1001
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Activation of AMP-activated protein kinase (AMPK) in endothelial cells regulates energy homeostasis, stress protection and angiogenesis, but the underlying mechanisms are incompletely understood. Using a label-free phosphoproteomic analysis, we identified glutamine:fructose-6-phosphate amidotransferase 1 (GFAT1) as an AMPK substrate. GFAT1 is the rate-limiting enzyme in the hexosamine biosynthesis pathway (HBP) and as such controls the modification of proteins by O-linked β-N-acetylglucosamine (O-GlcNAc). In the present study, we tested the hypothesis that AMPK controls O-GlcNAc levels and function of endothelial cells via GFAT1 phosphorylation using biochemical, pharmacological, genetic and in vitro angiogenesis approaches. Activation of AMPK in primary human endothelial cells by 5-aminoimidazole-4-carboxamide riboside (AICAR) or by vascular endothelial growth factor (VEGF) led to GFAT1 phosphorylation at serine 243. This effect was not seen when AMPK was down-regulated by siRNA. Upon AMPK activation, diminished GFAT activity and reduced O-GlcNAc levels were observed in endothelial cells containing wild-type (WT)-GFAT1 but not in cells expressing non-phosphorylatable S243A-GFAT1. Pharmacological inhibition or siRNA-mediated down-regulation of GFAT1 potentiated VEGF-induced sprouting, indicating that GFAT1 acts as a negative regulator of angiogenesis. In cells expressing S243A-GFAT1, VEGF-induced sprouting was reduced, suggesting that VEGF relieves the inhibitory action of GFAT1/HBP on angiogenesis via AMPK-mediated GFAT1 phosphorylation. Activation of GFAT1/HBP by high glucose led to impairment of vascular sprouting, whereas GFAT1 inhibition improved sprouting even if glucose level was high. Our findings provide novel mechanistic insights into the role of HBP in angiogenesis. They suggest that targeting AMPK in endothelium might help to ameliorate hyperglycaemia-induced vascular dysfunction associated with metabolic disorders.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Läkemedelskemi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Medicinal Chemistry (hsv//eng)

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view